Merit Medical Systems is a medical - instruments & supplies company in the healthcare sector trading on NASDAQ, led by CEO Martha Goldberg Aronson, with a market cap of $4.1B.
Upcoming earnings announcement for Merit Medical Systems
Past 12 earnings reports for Merit Medical Systems
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 24, 2026 | Q4 2025 | $1.04Est: $0.91 | +14.3% | $393.9MEst: $390.9M | +0.8% | |
| Oct 30, 2025 | Q3 2025 | $0.92Est: $0.79 | +16.5% | $384.2MEst: $371.5M | +3.4% | |
| Jul 30, 2025 | Q2 2025 | $1.01Est: $0.82 | +23.2% | $382.5MEst: $375.0M | +2.0% | |
| Apr 24, 2025 | Q1 2025 | $0.86Est: $0.75 | +14.7% | $355.4MEst: $352.6M | +0.8% | |
| Feb 25, 2025 | Q4 2024 | $0.93Est: $0.83 | +12.0% | $355.2MEst: $351.5M | +1.0% | |
| Oct 30, 2024 | Q3 2024 | $0.86Est: $0.80 | +7.5% | $339.8MEst: $334.6M | +1.6% | |
| Aug 1, 2024 | Q2 2024 | $0.92Est: $0.87 | +5.7% | $338.0MEst: $334.6M | +1.0% | |
| Apr 30, 2024 | Q1 2024 | $0.77Est: $0.71 | +8.5% | $323.5MEst: $315.5M | +2.5% | |
| Feb 28, 2024 | Q4 2023 | $0.81Est: $0.76 | +6.6% | $324.5MEst: $320.0M | +1.4% | |
| Oct 26, 2023 | Q3 2023 | $0.75Est: $0.65 | +15.4% | $315.2MEst: $306.3M | +2.9% | — |
| Jul 25, 2023 | Q2 2023 | $0.81Est: $0.75 | +8.0% | $320.1MEst: $310.5M | +3.1% | — |
| Apr 26, 2023 | Q1 2023 | $0.64Est: $0.55 | +16.4% | $297.6MEst: $280.5M | +6.1% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.